Focus Partners Wealth
TMO icon

Focus Partners Wealth’s Thermo Fisher Scientific TMO Stock Holding History

Focus Partners Wealth’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$431M Sell
860,536
-280,416
-25% -$135M 0.44% 44
2026
Q1 		$561M Buy
1,140,952
+196,196
+21% +$106M 0.62% 32
2025
Q4 		$547M Buy
944,756
+686,009
+265% +$388M 0.62% 34
2025
Q3 		$126M Buy
258,747
+2,947
+1% +$1.37M 0.2% 91
2025
Q2 		$104M Buy
255,800
+36,179
+16% +$15.1M 0.22% 94
2025
Q1 		$109M Buy
219,621
+247
+0.1% +$134K 0.27% 76
2024
Q4 		$114M Buy
219,374
+3,682
+2% +$2.02M 0.3% 66
2024
Q3 		$133M Sell
215,692
-186,432
-46% -$110M 0.43% 47
2024
Q2 		$222M Buy
402,124
+378,030
+1,569% +$217M 0.75% 28
2024
Q1 		$14M Buy
24,094
+5,363
+29% +$3.01M 0.11% 177
2023
Q4 		$9.94M Buy
+18,731
New +$9.07M 0.13% 152

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Focus Partners Wealth's TMO Position: Q2 2026 in Review

Focus Partners Wealth reduced its Thermo Fisher Scientific (TMO) stake by 25% in Q2 2026, selling an estimated $135M and leaving 860,536 shares worth $431M. The position accounts for 0.44% of the portfolio, ranked #44.

Focus Partners Wealth first reported a position in TMO in Q4 2023 and has held it in 11 quarters since. The position peaked at $561M in Q1 2026. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Focus Partners Wealth held 860,536 shares of Thermo Fisher Scientific worth $431M as of Q2 2026.
  • Focus Partners Wealth sold 280,416 Thermo Fisher Scientific shares in Q2 2026, an estimated $135M.
  • Thermo Fisher Scientific made up 0.44% of Focus Partners Wealth's portfolio in Q2 2026, its #44 holding.
  • Focus Partners Wealth first reported a position in Thermo Fisher Scientific in Q4 2023 and has held it in 11 quarters since.
  • Focus Partners Wealth's Thermo Fisher Scientific position peaked at $561M in Q1 2026.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Focus Partners Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.